376 related articles for article (PubMed ID: 18615677)
21. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
22. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.
Helmrich A; Stout-Weider K; Hermann K; Schrock E; Heiden T
Genome Res; 2006 Oct; 16(10):1222-30. PubMed ID: 16954539
[TBL] [Abstract][Full Text] [Related]
23. Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene.
Sawińska M; Schmitt JG; Sagulenko E; Westermann F; Schwab M; Savelyeva L
Genes Chromosomes Cancer; 2007 Nov; 46(11):991-9. PubMed ID: 17668870
[TBL] [Abstract][Full Text] [Related]
24. RORA, a large common fragile site gene, is involved in cellular stress response.
Zhu Y; McAvoy S; Kuhn R; Smith DI
Oncogene; 2006 May; 25(20):2901-8. PubMed ID: 16462772
[TBL] [Abstract][Full Text] [Related]
25. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site.
Letessier A; Millot GA; Koundrioukoff S; Lachagès AM; Vogt N; Hansen RS; Malfoy B; Brison O; Debatisse M
Nature; 2011 Feb; 470(7332):120-3. PubMed ID: 21258320
[TBL] [Abstract][Full Text] [Related]
26. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
Tsantoulis PK; Kotsinas A; Sfikakis PP; Evangelou K; Sideridou M; Levy B; Mo L; Kittas C; Wu XR; Papavassiliou AG; Gorgoulis VG
Oncogene; 2008 May; 27(23):3256-64. PubMed ID: 18084328
[TBL] [Abstract][Full Text] [Related]
27. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
[TBL] [Abstract][Full Text] [Related]
28. Induction of the common fragile site FRA3B does not affect FHIT expression.
Michael D; Rajewsky MF
Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
[TBL] [Abstract][Full Text] [Related]
30. Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
Büttel I; Fechter A; Schwab M
Ann N Y Acad Sci; 2004 Dec; 1028():14-27. PubMed ID: 15650228
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer.
Denison SR; Becker NA; Ferber MJ; Phillips LA; Kalli KR; Lee J; Lillie J; Smith DI; Shridhar V
Genes Chromosomes Cancer; 2002 Aug; 34(4):406-15. PubMed ID: 12112530
[TBL] [Abstract][Full Text] [Related]
32. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
[TBL] [Abstract][Full Text] [Related]
33. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
[TBL] [Abstract][Full Text] [Related]
34. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.
Blumrich A; Zapatka M; Brueckner LM; Zheglo D; Schwab M; Savelyeva L
Hum Mol Genet; 2011 Apr; 20(8):1488-501. PubMed ID: 21258086
[TBL] [Abstract][Full Text] [Related]
35. Low-frequency common fragile sites: link to neuropsychiatric disorders?
Savelyeva L; Sagulenko E; Schmitt JG; Schwab M
Cancer Lett; 2006 Jan; 232(1):58-69. PubMed ID: 16298041
[TBL] [Abstract][Full Text] [Related]
36. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
Matzner I; Savelyeva L; Schwab M
Cancer Lett; 2003 Jan; 189(2):207-19. PubMed ID: 12490314
[TBL] [Abstract][Full Text] [Related]
37. Common fragile sites: mechanisms of instability revisited.
Debatisse M; Le Tallec B; Letessier A; Dutrillaux B; Brison O
Trends Genet; 2012 Jan; 28(1):22-32. PubMed ID: 22094264
[TBL] [Abstract][Full Text] [Related]
38. Impaired Replication Timing Promotes Tissue-Specific Expression of Common Fragile Sites.
Maccaroni K; Balzano E; Mirimao F; Giunta S; Pelliccia F
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32204553
[TBL] [Abstract][Full Text] [Related]
39. The molecular basis of common and rare fragile sites.
Schwartz M; Zlotorynski E; Kerem B
Cancer Lett; 2006 Jan; 232(1):13-26. PubMed ID: 16236432
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer.
Callahan G; Denison SR; Phillips LA; Shridhar V; Smith DI
Oncogene; 2003 Jan; 22(4):590-601. PubMed ID: 12555072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
